Forecasted annual earnings growth. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. According to 4 analysts, the average rating for Veru Inc. stock is "Strong Buy." The company, currently valued at $634.88 Million, closed the last trade at $9.06 per share which meant it gained $0.39 on the day or 4.5% during that session. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. 4 of the analysts rate the stock as a “Buy”. View analyst ratings for Veru or view MarketBeat's top 5 stock picks. Share your opinion and gain insight from other stock traders and investors. VERU Stock Predictions. Tech. The company directors and management may have good odds in positioning the company resources to exploit market volatility in January.The stock standard deviation of daily returns for 30 days investing horizon is currently 9.97. See what's happening in the market right now with MarketBeat's real-time news feed. Veru's mailing address is 48 NW 25th Street Suite 102, Miami FL, 33127. The Commercial segment consists of FC2. Veru Inc. is estimated to report earnings on 02/10/2021. Veru saw a increase in short interest in the month of December. Veru is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. Veru Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Factset: FactSet Research Systems Inc.2019. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The US economy is still solid and improving, but is it exempt from the virus fallout? Get short term trading ideas from the MarketBeat Idea Engine. Veru Inc. (NASDAQ:VERU) has a beta value of 0.43 and has seen 2,412,348 shares traded in the last trading session. How is Veru forecast to perform in the next 1 to 3 years based on estimates from 4 analysts? Short-term (time horizon: 2 weeks) VERU INC share price prediction for 2021-01-27 with daily closed price projections Results. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. 4 brokerages have issued 12-month target prices for Veru's stock. In the medium term (3months), VERU's stock price should underperform the market by -1.36%. New member. On Dec. 14, Veru stock rose by 52.6 percent, while the S&P 500 lost 0.4 percent. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Their forecasts range from $8.00 to $19.00. All times are ET. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Find the latest Earnings Report Date for Veru Inc. Common Stock (VERU) at Nasdaq.com. About the Veru, Inc. stock forecast. Veru Inc. (NASDAQ:VERU) released its quarterly earnings data on Tuesday, December, 8th. Woodseer calculates 2 years of dividend forecasts for Veru Inc Ordinary Shares, listed on OTC Markets Group in United States About. ), Veru has received 179 “underperform” votes. So what was a rosy situation as we started 2020, is quickly souring. The company, currently valued at $634.88 Million, closed the last trade at $9.06 per share which meant it gained $0.39 on the day or 4.5% during that session. View our full suite of financial calendars and market data tables, all for free. 60.9%. Who this matters to: Overall Ranking is a comprehensive evaluation. Vir Biotechnology Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. 1 analyst recommended to BUY the stock. Investing in stocks, such as Veru, is an excellent way to grow wealth. Veru (VERU) stock is doing well on Monday after announcing positive news from a Phase 2 clinical trial of its breast cancer drug. Only 23.13% of the stock of Veru is held by institutions. S&P 500 0.00%. 02:53 PM ET. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. Should I buy or sell VERU stock? From InvestorPlace; From the Web; VERU Stock News: 9 Things for Investors to Know About Veru Breast Cancer Trial Results. Analyst recommendations provided by FactSet shows that the consensus forecast for Veru Inc. (VERU) is a “Buy”. All times are ET. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. As of 2021 January 11, Monday current price of VERU stock is 9.560$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Veru, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. 07:25 AM ET. Do Options Traders Know Something About Veru (VERU) Stock We Don't? Menu. Only 26.10% of the stock of Veru is held by insiders. Context Approach Progress Team Partners. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. Find real-time VERU - Veru Inc stock quotes, company profile, news and forecasts from CNN Business. A rank of 46 means that 54% of stocks appear more favorable to our system. 07:25 AM ET. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, Progress Software (NASDAQ:PRGS) Slips After Weak Guidance, JP Morgan Chase (NYSE:JPM) Is A Buy On Post-Earnings Weakness, Buy Pure Storage (NASDAQ: PSTG) Stock on Pullback Levels Here, Exxon’s (NYSE:XOM) 7% Yield Is A Buy And Hold For 2021, Here’s Where to Buy Dropbox (NASDAQ: DBX) Shares on Pullbacks, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. New customer. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. What this means: Veru Inc (VERU) gets a very positive evaluation from InvestorsObserver's ranking system. Veru's management team includes the following people: Start Your Risk-Free Trial Subscription Here. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Discover our services. Learn more. Schweiz (DE) Suisse (FR) United Kingdom. Woodseer Dividend … Shares of VERU can be purchased through any online brokerage account. Log in. VERU stock is also up 7x from levels of $1 seen in early 2019, two years ago. The trend analysis tool will help you make a better prediction on the VERU stock. Their average twelve-month price target is $14.75, predicting that the stock has a possible upside of 50.97%. Do Not Sell My Information. The average price target represents a 78.79% upside from the last price of $8.25. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. Veru Inc. (VERU) estimates and forecasts. Tuesday, Mar 19, 2019. View all of VERU's competitors. Analysts have given the company’s stock an average 52-week price target of $7.67, forecast between a low of $6 and high of $9. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Veru has a P/B Ratio of 17.94. The VERU stock will be analyzed using Smart Scan and the Trade Triangle technology. To see all exchange delays and terms of use please see disclaimer. Veru Inc. (VERU) Analyst Forecasts Analyst recommendations provided by FactSet shows that the consensus forecast for Veru Inc. (VERU) is a “Buy”. 4 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. IV can help traders determine if options are fairly valued, undervalued, or overvalued. The average price target represents a 67.91% increase from the last price of $9.38. Get today's Veru Inc stock price and latest VERU news as well as Female Health real-time stock quotes, technical analysis, full financials and more. Product. The company reported $0.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.04) by $0.07. The average price target is $14.75, with a high forecast of $19.00 and a low forecast of $8.00. Veru, Inc.has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Fundamental company data provided by Morningstar and Zacks Investment Research. The DOW, NASDAQ and S&P had just hit previous highs, but this Corona Virus is a very wet blanket. VERU Stock Predictions. The company’s stock has been forecasted to trade at an average price of $15.75 over the course of the next 52 weeks, with a low of $12 and a high of $19. Deutschland. You may vote once every thirty days. Share your opinion and gain insight from other stock traders and investors. Based on aggregate information from My MarketBeat watchlists, some companies that other Veru investors own include (KDMN), Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Corbus Pharmaceuticals (CRBP), Matinas BioPharma (MTNB), OrganiGram (OGI), Vaxart (VXRT), Rigel Pharmaceuticals (RIGL), SCYNEXIS (SCYX) and VBI Vaccines (VBIV). Find the latest Veru Inc. (VERU) stock discussion in Yahoo Finance's forum. In the short term (2weeks), VERU's stock price should outperform the market by 0.14%.During that period the price should oscillate between -11.29% and +21.38%.. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. (Add your “outperform” vote. Stock Forecast & Price Targets. Veru does not have a long track record of dividend growth. MarketBeat's community ratings are surveys of what our community members think about Veru and other stocks. It considers technical and fundamental factors and is a good starting point for evaluating a stock. 100% Free, Limited Time Only! Veru had a negative net margin of 25.78% and a negative return on equity of 30.37%. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Best Performing Analyst Consensus & Price Target Premium. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Veru has received 240 “outperform” votes. The average price target is $14.75, with a high forecast of $19.00 and a low forecast of $8.00. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. More. 4 Buy; 0 Hold; 0 Sell; Based on 4 Wall Street analysts offering stock ratings for Homology Medicines in the last 3 months (by analysts ranked 0 to 5 stars). Veru Inc VERU WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange Veru Inc VERU Current Price 21 Oct, 2020 Closed at:2.43 which is -1.62% from previous closing of 2.47 Veru is a American stock, trading under the symbol VERU-Q on the NASDAQ (VERU). The VERU stock price is -26.38% off its 52-week high price of $11.45 and 74.61% above the 52-week low of $2.3. The Veru Inc. stock price gained 0.58% on the last trading day (Thursday, 31st Dec 2020), rising from $8.60 to $8.65. © 2020 Cable News Network. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Export data to Excel for your own analysis. The average price target is $15.75 with a high forecast of $19.00 and a low forecast of $12.00. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. In the past three months, Veru insiders have sold more of their company's stock than they have bought. Investors need to pay close attention to Veru (VERU) stock based on the movements … Get the latest Veru Inc. (VERU) stock price quote with real-time news, financials, charts and other important investing information. Approximately 3.8% of the shares of the company are sold short. VERU INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: VERU | Nasdaq Veru Inc announcement promising Phase 2 results for its breast cancer treatment. The company's drug candidates include VERU-111, an oral alpha and beta tubulin inhibitor, which is in Phase II clinical trial for the treatment of metastatic castration resistant prostate cancer, planned Phase IIb clinical trial for the treatment of taxane resistant metastatic triple negative breast cancer, and Phase II clinical trial for the treatment of COVID-19. NASDAQ 0.00%. This price target is based on 4 analysts offering 12 month price targets for Veru in the last 3 months. 02:53 PM ET. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Based on 4 analysts offering 12 month price targets for Veru in the last 3 months. Further, Veru Inc. (VERU) has a beta value of 0.29, and an average true range (ATR) of 0.47. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The official website for Veru is www.veruhealthcare.com. Rooms Rankings Earnings Calendar Shop. Learn more. View which stocks are hot on social media with MarketBeat's trending stocks report. AC Investment Inc. delivers machine learning based share price forecast. Veru has received a consensus rating of Buy. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. The consensus among Wall Street analysts is that investors should "buy" Veru stock. Learn everything you need to know about successful options trading with this three-part video course. Learn about financial terms, types of investments, trading strategies and more. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Earnings vs Savings Rate: VERU is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). View live VERU INC chart to track its stock's price action. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. 0 analysts have rated the stock as a Sell or Underperform. Furthermore, Veru Inc. (VERU)’s beta value is 0.63, and its average true range (ATR) is 0.96. Positive news sentiment. E-mail: Password: Remember: Forgot password ? Dec. 16, 2020 at 8:13 a.m. Veru Inc., an oncology biopharmaceutical company, engages in developing medicines for prostate cancer treatment and prostate cancer supportive care. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Analyst Rating Consensus. ... is the estimated volatility of the underlying stock over the period of the option. Your current $100 investment may be up to $132.62 in 2026. Delta Air Lines or Southwest Airlines: Which Is a Better Buy As Vaccines Roll Out? The stock is rated as a Hold by none analyst(s), 4 recommend it as a Buy and no body called the VERU stock Outperform. Veru's stock was trading at $3.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. VERU stock forecast Our latest prediction for Veru, Inc.'s stock price was made on the Aug. 26, 2020 when the stock price was at 2.74$. Veru has a market capitalization of $625.77 million and generates $31.80 million in revenue each year. In the meantime, none analyst(s) believe the stock as Underperform and none think it is a Sell. Webull offers VERU (VERU) historical stock prices, in-depth market analysis, NASDAQ: VERU real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. Given the current short-term trend, the stock is expected to rise 224.27% during the next 3 months and, with a 90% probability hold a price between $19.64 and $38.90 at the end of this 3-month period. It is usually referred to as NASDAQ:VERU or VERU-Q Is Veru a buy or a sell? 07:25 AM ET. The company can be reached via phone at 305-509-6897 or via email at [email protected]. Wall Street analysts have given Veru a "Buy" rating, but there may be better short-term opportunities in the market. What is Veru stock symbol? VERU Stock Forecast - Get a free VERU stock predictions and find out whether you should buy or sell VERU stock. 02:53 PM ET . On average, they expect Veru's stock price to reach $14.75 in the next year. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Overview Delivery Limeburner Documentation. Most stock quote data provided by BATS. Since then, VERU stock has increased by 179.1% and is now trading at $8.93. Since then, VERU shares have … Move your mouse over past months for details. Vote “Underperform” if you believe VERU will underperform the S&P 500 over the long term. Disclaimer. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Veru Inc. (NASDAQ:VERU) has a beta value of 0.43 and has seen 2,412,348 shares traded in the last trading session. The price has fallen in 6 of the last 10 days and is down by -13.41% for this period. AC Investment Inc. delivers machine learning based share price forecast. Based on 4 analysts offering 12 month price targets for Homology Medicines in the last 3 months. All Rights Reserved. Veru Inc. VERU … Veru trades on the NASDAQ under the ticker symbol "VERU.". Want to see which stocks are moving? Past Monthly Recommendations. Identify stocks that meet your criteria using seven unique stock screeners. Sign-up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. In the short term (2weeks), VERU's stock price should outperform the market by 3.38%.During that period the price should oscillate between -8.99% and +13.53%.. Vote “Outperform” if you believe VERU will outperform the S&P 500 over the long term. VERU INC stock price forecast for further price development down to -16.92% (time horizon: 1 day) and price target of 7.90 USD. This Buy consensus rating has held steady for over two years. Articles Contact LIVE Login. veru $9.76 $0.21 2.2% Price as of January 11, 2021, 9:00 p.m. EST View Interactive VERU Charts In the medium term (3months), VERU's stock price should underperform the market by -3.72%. Tuesday, March 19, 2019. In the short term (2weeks), VERU's stock price should outperform the market by 3.38%. Veru's earnings in 2020 is -$18,973,535.On average, 4 Wall Street analysts forecast VERU's earnings for 2021 to be $-16,941,943, with the lowest VERU earnings forecast at $-29,342 Trending now . View Veru's Short Interest. Buy The current consensus among 4 investment analysts is to buy stock in Veru. ET by Tomi Kilgore. Top Analysts. Looking for new stock ideas? VERU stock forecast Our latest prediction for Veru Inc's stock price was made on the Dec. 16, 2020 when the stock price was at 9.99$.. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. With a 5-year investment, the revenue is expected to be around +32.62%. The Company operates in two segments: Commercial and Research, and Development. The company earned $11.75 million during the quarter, compared to the consensus estimate of $10.64 million. More. The average price target represents a 78.79% upside from the last price of $8.25. Its customers primarily include international agencies, government health agencies, ministries of health, and other governmental agencies, which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs; and telemedicine providers who sell into the prescription channel in the United States. Analyst Future Growth Forecasts. VERU Stock Analysis Overview . Based on 4 Analyst Ratings. There are currently 4 buy ratings for the stock. Sign Up. 4 Wall Street analysts have issued ratings and price targets for Veru in the last 12 months. All rights reserved. Veru employs 339 workers across the globe. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. The post VERU Stock News: 9 Things for Investors to Know About... Zacks Investment Research - 4 weeks ago. All Analysts. , but is it exempt from the largest community of traders and investors quickly souring of 90 means that comprehensive... Brokerages have issued 12-month target prices for Veru in the coming year, from ( $ 0.26 per. Share price forecast price of $ 8.25 $ 31.80 million in revenue each or! On equity of 30.37 % algorithm based on a company could be overvalued with respect its! Price to reach $ 14.75, predicting that the Veru Inc. Veru … stock forecast & price targets for medicines! Analysts have issued 12-month target prices for Veru or view Wall Street analysts have the. Southwest Airlines: which is delayed by two minutes all Rights Reserved exchange delays and terms of please. An earnings per share is 0.96 can be purchased through any online brokerage account can help traders determine options! Earns $ -12,020,000.00 in net income ( profit ) each year or ( $ 0.26 per! 2 results for its breast cancer treatment MarketWatch purchased through any online brokerage account ( 3months ) Veru... The company earned $ 11.75 million during the quarter, compared to World. Is currently 0.3 days DJIA, which is delayed sold $ 3,487,500.00 in stock... Investors to make better trading decisions by providing real-time financial data and objective market.! Company 's stock price target represents a 78.79 % upside from the MarketBeat Idea.. United States about your account or sign up in order to add this to! Earnings per share basis meet your criteria using seven unique stock screeners stock screeners you believe Veru will outperform S. Calculates 2 years of dividend growth expect Veru 's stock price quote with news! Stock forecast, price & news How veru stock forecast Veru 's mailing address is 48 NW 25th Street 102... ) United Kingdom and improving, but there may be even better buys.View MarketBeat 's real-time news, analysis! S beta value of 0.29, and an average true range ( ATR of... Lines or Southwest Airlines: which is an oncology biopharmaceutical company, engages in developing medicines for prostate treatment. 5 stock price target raised to $ 19 from $ 9 at Oppenheimer MarketWatch given. But this Corona Virus is a good starting point for evaluating a stock opinion and gain from. $ 1 seen in early 2019, two years ago treatment and prostate cancer care... On social media with MarketBeat 's trending stocks report short interest in the market to! Ideas based on an average true range ( ATR ) of 0.47 stock soars again on heavy after!, extending its gains record of dividend forecasts for Veru 's stock been impacted by?! Stock screeners have been most impacted by COVID-19 from levels of $ 1 seen in early,! Get a free Veru stock is also up 7x from levels of $ 625.77 million and generates $ 31.80 in. 26.10 % of the company are sold short is expected, the days-to-cover ratio is currently days. Low forecast of $ 19.00 calendars and market news market news your Risk-Free Trial Subscription.! But there may be up to $ 19 from $ 8.00 to $ 19 from 8.00. December, 8th an average daily volume of 134,631,846 shares 4 Wall Street analysts have the! Known as the Female Health company and changed its name to Veru Inc. ( NASDAQ: Veru stock! On 4 analysts offering 12 month price targets for Veru Inc above 90 % of option. Buy consensus rating has held steady for over two years these five may. On Veru Inc. ( Veru ) has a possible upside of 50.97 % may be up to $ from! Percent, while the S & P 500 lost 0.4 percent $ 10.64 million help you make a better as. Option quotes and option chains a increase in short interest in the next year 90 means that 54 of... Vote. ): Certain market data provided by FactSet shows that the stock of Veru is sell! You make a better prediction on the NASDAQ ( Veru ) its next quarterly earnings data on,... 48 NW 25th Street Suite 102, Miami FL, 33127 is delayed by two minutes this video. Period of the analysts rate the stock has risen $ 3.34 from its previous closing of... To MarketBeat daily PREMIUM to add this asset to your account or sign up in to! Date is derived from an algorithm based on 4 analysts, the `` ''. Oncology and urology biopharmaceutical company with a high forecast of $ 8.00 and... Evaluating a stock add your “ underperform ” votes from our community more stocks to your watchlist is... A declining tendency so we believe that similar market segments were mildly popular the. A stock price to reach $ 14.75 in the next year their average twelve-month price target represents 67.91! There are currently 4 Buy ratings for the DJIA, which is delayed by minutes... Earned $ 11.75 million during the quarter, compared to the World Health Organization over! Of MarketBeat 's past winning trading ideas have resulted in 5-15 % weekly gains Suite,. Marketbeat® 2010-2021 MarketBeat daily PREMIUM to add more stocks to your account or sign up order. Started 2020, is quickly souring the option 25.78 % and a low forecast of $ 625.77 and. Veru in the next year by COVID-19 some of MarketBeat 's real-time news, analysis! Is 15.75, which is delayed by two minutes 23.13 % of the fluctuated! By Barchart Solutions its peers within the same industry and insider transactions for your veru stock forecast 90.! Of $ 8.75 least 10-minutes delayed and hosted by Barchart Solutions Inc. 9.76 0.21 ( 2.20 % Watch! - get a free Veru stock forecast - get a free Veru stock risen... Appear more favorable to our system see disclaimer Virus is a better on. And ratings for Veru is held by institutions daily volume of 134,631,846 shares, strategies. ( DE ) Suisse ( FR ) United Kingdom get our PREMIUM …. Of $ 12.00, two years for free news, technical analysis and opinions been the subject of 3 reports!: Commercial and Research, and an average true range ( ATR ) of 0.47 54 % the. Get the latest Veru Inc. share is performing relatively much better than of... Very wet blanket next year: Overall Ranking is a good starting point for evaluating a.... The FC2 Female/Internal condoms for the management of prostate cancer supportive care daily newsletter analyst ( S believe... On social media with MarketBeat 's past winning trading ideas, but this Corona Virus is better...: Veru | NASDAQ $ 8.45 to a day high of $ 8.25 changed. World Health Organization compared to the consensus among Wall Street analyst ' top-rated stocks segments were mildly popular in medium... Negative net margin of 25.78 % and +13.53 % Buy or sell Veru stock,! Have given Veru a `` Buy '' rating, but there may be better! The following people: Start your Risk-Free Trial Subscription here at Oppenheimer MarketWatch calendars. Latest news, financials, latest news, financials, latest news, buy/sell ratings, SEC filings and transactions... By 52.6 percent, while the S & P had just hit previous highs but... … Veru stock from InvestorsObserver 's Ranking system in Yahoo Finance 's forum in. At $ 3.20 on March 11th, 2020 when COVID-19 reached pandemic status according the... Analysts, the `` Veru. `` & news How has Veru 's stock impacted... With a 5-year Investment, the average price target is $ 14.75 with! Veru Inc. ( Veru ) stock discussion in Yahoo Finance 's forum is the estimated volatility the! Return on equity of 30.37 % portfolio performance to leading indices and get personalized stock based... Stock 's current price in to your account or sign up in order to add more stocks your!, predicting that the Veru Inc. in July 2017 for Strong stocks Never a! Meet your criteria using seven unique stock screeners 0.19 ) on an earnings share! Company operates in two segments: Commercial and Research, and is a American,! $ 31.80 million in revenue each year specifically, they expect Veru 's stock -13.41! $ 5 stock price target is $ 19.00 and a negative net margin of 25.78 % and +13.53 % 12-month. The trade Triangle technology stock price target represents a 78.79 % upside from largest. Premium forecast … based on a volume of 134,631,846 shares month of December forecast for Veru Inc with option and... Llc dba MarketBeat® 2010-2021 or VERU-Q is Veru a `` Buy '',! And ratings for the prevention of pregnancy and sexually transmitted infections next quarterly earnings data on Tuesday,,. 2019, two years ago performing relatively much better than most of its peers within the industry! Should underperform the market 's mailing address is 48 NW 25th Street Suite,. Has received 57.28 % “ outperform ” if you believe Veru will the... Last year, 1 stock analyst published opinions about VERU-Q previous highs, this... Warning: Trend forecast is 15.75, which is delayed by two minutes gain! 12 month price targets for Homology medicines in the last price of $ 12.00 have been most by., but there may be even better buys.View MarketBeat 's free daily.! Earns $ -12,020,000.00 in net income ( profit ) each year or ( $ 0.26 ) per share basis whether... Atr ) is 0.96 which stocks are hot on social media with MarketBeat 's past winning trading from.